{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:17Z","timestamp":1792788257479,"version":"4.5.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.msard.2026.107889","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:48:34Z","timestamp":1787849314000},"page":"107889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Risk of misclassifying steroid-modified lymphoma under the proposed management algorithm for Marburg variant of multiple sclerosis"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6502-5071","authenticated-orcid":false,"given":"Akira","family":"Hanazono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinako","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Sanpei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107889_bib0001","first-page":"490","article-title":"The role of mitoxantrone in non-hodgkin\u2019s lymphoma","volume":"16","author":"Armitage","year":"2002","journal-title":"Oncol. (Williston Park)"},{"key":"10.1016\/j.msard.2026.107889_bib0002","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/bpa.12496","article-title":"Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination","volume":"28","author":"Barrantes-Freer","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.msard.2026.107889_bib0003","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/NEN.0000000000000076","article-title":"CNS lymphoma: a practical diagnostic approach","volume":"73","author":"Giannini","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.msard.2026.107889_bib0004","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/neuonc\/noy192","article-title":"Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma","volume":"21","author":"Grommes","year":"2019","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.msard.2026.107889_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2024.100515","article-title":"Diagnostic uncertainty of steroid-modified Marburg\u2019s variant of multiple sclerosis even at autopsy: a case suggesting lymphoma and related myelin loss","volume":"36","author":"Hanazono","year":"2024","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.msard.2026.107889_bib0006","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00281-009-0178-z","article-title":"The pathological spectrum of CNS inflammatory demyelinating diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.msard.2026.107889_bib0007","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/ejh.13369","article-title":"High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin\u2019s lymphoma, a phase II result","volume":"104","author":"Michot","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.msard.2026.107889_bib0008","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107889_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106908","article-title":"Towards practical management of the Marburg variant of multiple sclerosis","volume":"106","author":"Sredanovi\u0107","year":"2026","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:22:45Z","timestamp":1792786965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826009247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":9,"alternative-id":["S2211034826009247"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107889","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of misclassifying steroid-modified lymphoma under the proposed management algorithm for Marburg variant of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107889"}}